Literature DB >> 10832771

Overweight, obesity, and blood pressure: the effects of modest weight reduction.

I L Mertens1, L F Van Gaal.   

Abstract

Several large epidemiological studies have shown an association between body mass index and blood pressure in normal weight and overweight patients. Weight gain in adult life especially seems to be an important risk factor for the development of hypertension. Weight loss has been recommended for the obese hypertensive patient and has been shown to be the most effective nonpharmacological treatment approach. However, long-term results of weight loss programs are disappointing with people often regaining most of the weight initially lost. In recent years, a modest weight loss, defined as a weight loss of 5% to 10% of baseline weight, has received increasing attention as a new treatment strategy for overweight and obese patients. A more gradual and moderate weight loss is more likely to be maintained over a longer period of time. Several studies have confirmed the blood pressure-lowering effect of a modest weight loss in both hypertensive and nonhypertensive patients. A modest weight loss can normalize blood pressure levels even without reaching ideal weight. In patients taking antihypertensive medication, a modest weight loss has been shown to lower or even discontinue the need for antihypertensive medication. In patients with high normal blood pressure, a modest weight loss can prevent the onset of frank hypertension. The blood pressure-lowering effect of weight loss is most likely a result of an improvement in insulin sensitivity and a decrease in sympathetic nervous system activity and occurs independent of salt restriction. In conclusion, a modest weight loss that can be maintained over a longer period of time is a valuable treatment goal in hypertensive patients.

Entities:  

Mesh:

Year:  2000        PMID: 10832771     DOI: 10.1038/oby.2000.32

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  66 in total

1.  Dietary intake of patients with schizophrenia.

Authors:  Martin Strassnig; Jaspreet Singh Brar; Rohan Ganguli
Journal:  Psychiatry (Edgmont)       Date:  2005-02

2.  Nine-year changes in cardiovascular disease risk factors with weight maintenance in the atherosclerosis risk in communities cohort.

Authors:  Kimberly P Truesdale; June Stevens; Jianwen Cai
Journal:  Am J Epidemiol       Date:  2007-01-27       Impact factor: 4.897

Review 3.  Weight reduction for treatment of obesity-associated hypertension: nuances and challenges.

Authors:  Allyn L Mark
Journal:  Curr Hypertens Rep       Date:  2007-11       Impact factor: 5.369

4.  Effect of gastrectomy on blood pressure in early gastric cancer survivors with hypertension.

Authors:  Hak Jin Kim; Eun Jeong Cho; Mi Hyang Kwak; Bang Wool Eom; Hong Man Yoon; Soo-Jeong Cho; Jong Yeul Lee; Chan Gyoo Kim; Keun Won Ryu; Young-Woo Kim; Il Ju Choi
Journal:  Support Care Cancer       Date:  2018-10-13       Impact factor: 3.603

5.  Disease risk factors identified through shared genetic architecture and electronic medical records.

Authors:  Li Li; David J Ruau; Chirag J Patel; Susan C Weber; Rong Chen; Nicholas P Tatonetti; Joel T Dudley; Atul J Butte
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

6.  ¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors.

Authors:  Heather Greenlee; Ann Ogden Gaffney; A Corina Aycinena; Pam Koch; Isobel Contento; Wahida Karmally; John M Richardson; Emerson Lim; Wei-Yann Tsai; Katherine Crew; Matthew Maurer; Kevin Kalinsky; Dawn L Hershman
Journal:  J Acad Nutr Diet       Date:  2015-05       Impact factor: 4.910

7.  Long-term activation of PKA in β-cells provides sustained improvement to glucose control, insulin sensitivity and body weight.

Authors:  Joshua A Levine; Kelly A Kaihara; Brian T Layden; Barton Wicksteed
Journal:  Islets       Date:  2016-06-24       Impact factor: 2.694

8.  Effect of 3-year weight history on blood pressure: the atherosclerosis risk in communities study.

Authors:  Kimberly P Truesdale; June Stevens; Jianwen Cai
Journal:  Obesity (Silver Spring)       Date:  2008-02-14       Impact factor: 5.002

9.  A randomised controlled trial of a community-based healthy lifestyle program for overweight and obese adolescents: the Loozit study protocol.

Authors:  Vanessa A Shrewsbury; Janice O'Connor; Katharine S Steinbeck; Kate Stevenson; Anthea Lee; Andrew J Hill; Michael R Kohn; Smita Shah; Siranda Torvaldsen; Louise A Baur
Journal:  BMC Public Health       Date:  2009-04-29       Impact factor: 3.295

10.  Effect of mitratapide on body composition, body measurements and glucose tolerance in obese Beagles.

Authors:  Britta Dobenecker; Manuelle De Bock; Marc Engelen; Lieve Goossens; Armin Scholz; Ellen Kienzle
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.